AUA

Anthony Herndon, MD

Protecting scientific integrity in the era of AI

The John Duckett Memorial Lecture examines the growing risks of AI-generated research and the urgent need for human oversight in medical publishing.

Balancing risks and benefits of hydrodistension for IC/BPS

Tyson With Crowd

New intravesical therapies show promise in NMIBC trials

Prolapse Panel 03

U-POP and LUTD care refined in international consensus report

From left: Kymora Scotland, MD, PhD; Taylor Brewer, MSM, PA; and Greg Tasian, MD, MSc, MSCE.

New stone guidelines sharpen focus on patient-centered care

Jaspreet S. Sandhu, MD

Updated BPH guidelines focus on patients, not procedures

New recommendations reflect evolving therapies, shared decision-making and changing evidence in BPH management.

Jennifer Robles, MD, MPH

Antibiotic use clarified in stone removal guidelines

Updated recommendations outline when prophylactic antibiotics are necessary—and when they can safely be avoided.

Find your next big break at AUA2026

Find your next big break at AUA2026

Connect with top health care employers from 10 a.m.-noon on Sunday, May 17.

Ben H. Chew, MD, MSc

Break Wave challenges standard lithotripsy approach

Trial finds low-pressure ultrasound cleared 70% of stones without anesthesia or adverse events.

Advocacy 02

Advocacy rewrites the label for HRT

A black box warning is lifted, marking a turning point for menopause care and a win for urology-led advocacy.

Sara M. Lenherr, MD, MS, URPS

Reinventing one of urology’s oldest tools

New approaches to catheter design could reduce complications and improve quality of life.

Find your next big break at AUA2026

Find your next big break at AUA2026

AUA means business: AUA Annual Business Meeting is May 18

AUA means business: AUA Annual Business Meeting is May 18

Unique formulation of YONSA® (abiraterone acetate) makes it different

Unique formulation of YONSA® (abiraterone acetate) makes it different

Book your AUA2026 housing now

Book your AUA2026 housing now

H. Gilbert Welch, MD, MPH

The hidden cost of looking harder for cancer

Aggressive screening distorts survival statistics and fuels unnecessary treatment in asymptomatic patients.

Neal Shore, MD

Durvalumab + BCG continues to deliver in high-risk NMIBC

Longest-running NMIBC trial shows sustained disease-free survival benefit and delayed cystectomy at five years.

Jean F.P. Lestingi, MD, PhD

Updated trial refines role of extended lymph node dissection

More than 10 years of follow-up reveal improved outcomes with EPLND in patients with ISUP grade 3-5 prostate cancer.

Mack Roach III, MD

The expanding role of biomarkers in prostate cancer

Experts examine the rapid rise of PSMA PET, genetic testing and novel biomarkers.

Hans Arora, MD, PhD

Urology’s many definitions of success

Young Urologists Forum spotlights non‑traditional career paths that merge passion with practice.

Welcome

Welcome to Washington, DC

AUA2026 opens with a call to challenge the norm.

Guidelines

Global experts to compare evolving prostate cancer guidelines at AUA Plenary panel

Neal Shore, MD and Zachary Klaassen, MD

Can you feel it?

Jeremy Teoh, MBBS

Rethinking TURBT in the era of robotics

J. Brandon Arrunda

Expanding the APP role in urology

Rana McKay, MD

Double take: Clinical trial looks at doublet treatment for mHSPC

Aua26 Readit

AUA2026: Read all about it

H. Gilbert Welch, MD, MPH

Rethinking cancer detection

Pain

The big shift

Hands On Courses

AUA2026 amps up hands-on skills training

Jeffrey A. Cadeddu, MD, FRCS

The great ablation debate

Daily Schedules

AUA2026 Daily Schedules

Bladder Transplant

Bladder transplantation changes the game